FDA is not aware of any cellular or gene therapies manufactured in China, and has identified no shortages of biologics as a result of supply chain disruptions from #COVID19 to report at this time: https://go.usa.gov/xddPn  

FDA is not aware of any cellular or gene therapies manufactured in China, and has identified no shortages of biologics as a result of supply chain disruptions from #COVID19 to report at this time: https://go.usa.gov/xddPn 
Source: Food and Drug Adminstration (FDA): CDRHNew - Category: Medical Devices Authors: Source Type: news